MENU
+Compare
LQDA
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$16.11
Change
-$0.39 (-2.36%)
Capitalization
1.36B

LQDA Liquidia Corp Forecast, Technical & Fundamental Analysis

a developer of particle-based vaccines and therapeutics for prevention and treatment of human disease

Industry Biotechnology
LQDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for LQDA with price predictions
Feb 18, 2025

LQDA sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for LQDA moved above the 200-day moving average on January 29, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LQDA advanced for three days, in of 292 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 163 cases where LQDA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LQDA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

LQDA broke above its upper Bollinger Band on February 05, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LQDA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (12.346) is normal, around the industry mean (12.604). P/E Ratio (0.000) is within average values for comparable stocks, (85.387). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.581). LQDA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (76.336) is also within normal values, averaging (252.111).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
LQDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

LQDA is expected to report earnings to rise 27.37% to -38 cents per share on March 13

Liquidia Corp LQDA Stock Earnings Reports
Q4'24
Est.
$-0.38
Q3'24
Beat
by $0.07
Q2'24
Missed
by $0.03
Q1'24
Missed
by $0.23
Q4'23
Missed
by $0.19
The last earnings report on November 13 showed earnings per share of -30 cents, beating the estimate of -37 cents. With 575.07K shares outstanding, the current market capitalization sits at 1.36B.
A.I. Advisor
published General Information

General Information

a developer of particle-based vaccines and therapeutics for prevention and treatment of human disease

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
419 Davis Drive
Phone
+1 919 328-4400
Employees
145
Web
https://www.liquidia.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY611.491.79
+0.29%
SPDR® S&P 500® ETF Trust
AAPL244.47-0.13
-0.05%
Apple
GME26.97-0.03
-0.11%
GameStop Corp
BTC.X95539.550000-233.835940
-0.24%
Bitcoin cryptocurrency
TSLA354.11-1.73
-0.49%
Tesla

LQDA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, LQDA has been loosely correlated with MTVA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if LQDA jumps, then MTVA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LQDA
1D Price
Change %
LQDA100%
+1.54%
MTVA - LQDA
44%
Loosely correlated
-1.43%
XERS - LQDA
31%
Poorly correlated
+7.80%
FOLD - LQDA
27%
Poorly correlated
+0.82%
PCVX - LQDA
26%
Poorly correlated
-1.82%
TRDA - LQDA
25%
Poorly correlated
-2.60%
More